Russell Investments Group Ltd. trimmed its holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Ranking) by 8.8% throughout the 1st quarter, in accordance with the corporate in its most up-to-date Kind 13F submitting with the SEC. The agency owned 46,730 shares of the life sciences firm’s inventory after promoting 4,482 shares throughout the quarter. Russell Investments Group Ltd. owned roughly 0.06% of Integra LifeSciences value $3,002,00Zero on the finish of the latest quarter.

Different hedge funds and different institutional buyers have additionally just lately modified their holdings of the corporate. ProShare Advisors LLC raised its holdings in shares of Integra LifeSciences by 24.6% within the fourth quarter. ProShare Advisors LLC now owns 8,403 shares of the life sciences firm’s inventory value $564,00Zero after shopping for a further 1,658 shares throughout the interval. First Horizon Advisors Inc. elevated its holdings in Integra LifeSciences by 428.4% throughout the 4th quarter. First Horizon Advisors Inc. now owns 1,189 shares of the life sciences firm’s inventory value $79,00Zero after buying a further 964 shares throughout the interval. State of New Jersey Widespread Pension Fund D elevated its holdings in Integra LifeSciences by 8.5% throughout the 4th quarter. State of New Jersey Widespread Pension Fund D now owns 40,793 shares of the life sciences firm’s inventory value $2,733,00Zero after buying a further 3,199 shares throughout the interval. Strs Ohio elevated its holdings in Integra LifeSciences by 6.3% throughout the 1st quarter. Strs Ohio now owns 89,699 shares of the life sciences firm’s inventory value $5,764,00Zero after buying a further 5,280 shares throughout the interval. Lastly, Trainer Retirement System of Texas elevated its holdings in Integra LifeSciences by 23.7% throughout the 4th quarter. Trainer Retirement System of Texas now owns 13,987 shares of the life sciences firm’s inventory value $937,00Zero after buying a further 2,682 shares throughout the interval. 93.32% of the inventory is presently owned by hedge funds and different institutional buyers.

Insider Transactions at Integra LifeSciences

In different information, Director Raymond G. Murphy bought 8,00Zero shares of the agency’s inventory in a transaction on Friday, August fifth. The inventory was bought at a median worth of $55.78, for a complete worth of $446,240.00. Following the completion of the sale, the director now owns 40,825 shares of the corporate’s inventory, valued at roughly $2,277,218.50. The transaction was disclosed in a authorized submitting with the Securities & Alternate Fee, which might be accessed via the SEC web site. In different Integra LifeSciences information, Director Raymond G. Murphy bought 8,00Zero shares of Integra LifeSciences inventory in a transaction dated Friday, August fifth. The inventory was bought at a median worth of $55.78, for a complete transaction of $446,240.00. Following the completion of the sale, the director now owns 40,825 shares of the corporate’s inventory, valued at roughly $2,277,218.50. The sale was disclosed in a authorized submitting with the SEC, which is accessible via this hyperlink. Additionally, EVP Lisa Evoli bought 1,165 shares of Integra LifeSciences inventory in a transaction dated Wednesday, August 10th. The inventory was bought at a median worth of $55.81, for a complete worth of $65,018.65. Following the sale, the manager vp now instantly owns 17,997 shares of the corporate’s inventory, valued at roughly $1,004,412.57. The disclosure for this sale might be discovered right here. Insiders bought 10,752 shares of firm inventory valued at $601,367 within the final quarter. 4.20% of the inventory is presently owned by company insiders.

Integra LifeSciences Inventory Up 1.6 %

Integra LifeSciences inventory opened at $57.07 on Friday. The corporate has a debt-to-equity ratio of 0.90, a present ratio of three.85 and a fast ratio of two.76. The inventory has a market capitalization of $4.77 billion, a price-to-earnings ratio of 28.97, a PEG ratio of 1.79 and a beta of 1.09. Integra LifeSciences Holdings Co. has a 1-year low of $51.21 and a 1-year excessive of $76.70. The enterprise has a fifty day shifting common worth of $55.41 and a 200-day shifting common worth of $60.65.

Wall Road Analyst Weigh In

IART has been the subject of a number of analysis studies. Piper Sandler diminished their worth goal on Integra LifeSciences from $66.00 to $55.00 in a report on Wednesday, July 27th. Truist Monetary diminished their worth goal on Integra LifeSciences from $70.00 to $56.00 and set a “maintain” score on the inventory in a report on Wednesday, July 20th. Citigroup dropped their goal worth on Integra LifeSciences from $70.00 to $67.00 and set a “impartial” score on the inventory in a analysis report on Tuesday, Could 17th. StockNews.com raised Integra LifeSciences from a “maintain” score to a “purchase” score in a analysis report on Saturday, April 30th. Lastly, TheStreet lower Integra LifeSciences from a “b-” score to a “c+” score in a analysis report on Friday, July eighth. One funding analyst has rated the inventory with a promote score, 5 have given a maintain score and three have issued a purchase score to the corporate’s inventory. Primarily based on information from MarketBeat, the inventory has a median score of “Maintain” and a median worth goal of $66.29.

About Integra LifeSciences

(Get Ranking)

Integra LifeSciences Holdings Company develops, manufactures, and markets surgical implants and medical devices to be used in neurosurgery, extremity reconstruction, and normal surgical procedure. It operates in two segments, Codman Specialty Surgical and Tissue Applied sciences. The corporate presents neurosurgery and neuro vital care merchandise, together with tissue ablation tools, dural restore merchandise, cerebral spinal fluid administration units, intracranial monitoring tools, and cranial stabilization tools; and surgical headlamps and instrumentation, in addition to asset administration software program and help, and after-market companies.

Learn Extra

Wish to see what different hedge funds are holding IART? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Ranking).

Obtain Information & Rankings for Integra LifeSciences Every day – Enter your electronic mail deal with under to obtain a concise every day abstract of the newest information and analysts’ scores for Integra LifeSciences and associated corporations with MarketBeat.com’s FREE every day electronic mail publication.